PSY19 THE COST-EFFECTIVENESS OF BORTEZOMIB PLUS MELPHALAN AND PREDNISONE VERSUS LENALIDOMIDE PLUS MELPHALAN AND PREDNISONE WITH CONTINUOUS LENALIDOMIDE MAINTENANCE TREATMENT FOR THE INITIAL TREATMENT OF MULTIPLE MYELOMA IN THE UNITED STATES ...
Abstract
Authors
S.T. Wang H. Huang A. Ba-mancini H. Shi K. Chen C. Korves R. Dhawan A. Cakana H. van de Velde M.S. Duh